Allarity Therapeutics Inc... (ALLR)
NASDAQ: ALLR
· Real-Time Price · USD
0.95
-0.03 (-3.04%)
At close: Aug 15, 2025, 3:59 PM
0.99
3.97%
After-hours: Aug 15, 2025, 07:15 PM EDT
Allarity Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.73M | -7.45M | -11.59M | -1.63M | -3.84M | -1.72M | -4.45M | -2.38M | -3.35M | -2.84M | -5.04M | -4.66M | -3.08M | -20.66M | 2.5M | -5.4M | -3.08M |
Depreciation & Amortization | 11K | 1K | 5K | 1K | 2K | 9K | 9K | 9K | 10K | 2K | 11K | 24K | 23K | 16K | 37K | -3K | 56K |
Stock-Based Compensation | 139K | 64K | 17K | 111K | -121K | -254K | 124K | 180K | -121K | 340K | 406K | -59K | 1.06M | 5.16M | 577K | 433K | 195K |
Other Working Capital | n/a | 3.51M | -106K | 84K | 566K | 661K | -74K | -521K | -198K | -793K | 1.29M | 242K | -7.55M | 6.65M | 843K | -207K | -409K |
Other Non-Cash Items | n/a | 276K | 9.71M | -2.12M | -2.84M | -3.28M | 764K | 489K | -309K | -611K | -267K | 206K | -22K | 2.96M | -4.81M | 848K | 535K |
Deferred Income Tax | n/a | n/a | -432K | n/a | -14K | 97K | -10K | -1.91M | n/a | -270K | -119K | 4K | -1.23M | 495K | -453K | -55K | 33K |
Change in Working Capital | n/a | 3.91M | -3.16M | -3.58M | 2.89M | 3.48M | -1.82M | 1.12M | 571K | 931K | 598K | 381K | -2.51M | 6.72M | -756K | -93K | -301K |
Operating Cash Flow | -2.69M | -3.21M | -5.44M | -7.22M | -1.49M | -1.67M | -5.38M | -2.5M | -3.2M | -2.45M | -4.41M | -3.91M | -5.75M | -5.31M | -2.91M | -4.27M | -2.57M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -298K | n/a | n/a | n/a | 116K | n/a | n/a | n/a | -18K | n/a | n/a | 809K | -3K | 1M | n/a | n/a |
Investing Cash Flow | n/a | -298K | n/a | n/a | n/a | 116K | n/a | -116K | n/a | -18K | n/a | n/a | 809K | -3K | 1M | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | -1.34M | 1.34M | -1.72M | 1.37M | -2.3M | n/a | 1M | n/a | n/a | n/a | -157K | 96K | -1.29M | 2.33M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | 6.65M | -5M | -1.65M | -2K | n/a | n/a | -1.51M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | -228K | n/a | n/a | n/a | n/a | -1.57M | n/a | n/a | -1.57M | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 2.24M | n/a | n/a | n/a | 1.57M | n/a | -800K | n/a | 1.34M | -542K | 12M | n/a |
Financial Cash Flow | 11.14M | 4.24M | 4.87M | 26.31M | 1.38M | 522K | 6.45M | 2.87M | 1.16M | 1M | n/a | -2.31M | -1.57M | 18.44M | 2.35M | 10.71M | 2.33M |
Net Cash Flow | 8.17M | 1.07M | -770K | 18.92M | 146K | -1.23M | 979K | 125K | -1.73M | -1.92M | -3.73M | -6.91M | -5.01M | 13.97M | -1.01M | 6.49M | -193K |
Free Cash Flow | -2.69M | -3.5M | -5.44M | -7.22M | -1.49M | -1.67M | -5.38M | -2.5M | -3.2M | -2.46M | -4.41M | -3.91M | -5.75M | -5.31M | -2.91M | -4.27M | -2.57M |